Pacific BioLabs will attend and exhibit at PBSS-SF Bay Area’s workshop on regulated bioanalysis (RBA). It is required in key parts of drug development that involve evaluations of drug safety, bioequivalence, and pharmacokinetics, and RBA data quality directly impacts the reliability of such assessments. RBA Method Validation requires compliance with various national method validation guidances, […]

PBL will be a proud exhibitor at the Cleaning Validation summit in October. It will feature lessons learned and case studies from industry experts and comprehensively cover: Understanding the 2018 FDA Guidance on Regulatory Submissions for Cleaning Validation Current Best Practices for Regulatory Audits of Cleaning and Cleaning Validation Practices ASTM Standards in Medical Device […]

The AAPS PharmSci  360 attracts pharmaceutical scientists who work across all stages of drug development including discovery, development and manufacture of pharmaceutical products and therapies. The sessions span preclinical development, clinical pharmacology, manufacturing and bioprocessing, formulation and quality.  

Pacific BioLabs is proud to be an exhibitor at the E&L conference. This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. In addition, this conference […]

Back for its 11th year, BIOMEDevice San Jose brings together more than 1,500 medical device industry professionals and 250+ suppliers on one floor for this premiere, must-attend event. Join other industry leaders and experts from across Silicon Valley’s booming medical device design and manufacturing community to learn more about the latest developments, trends, and technological breakthroughs across […]